Osteosarcoma (OSA) is lethal when metastatic after chemotherapy and/or surgical treatment. Thus animal models are necessary to study the OSA metastatic spread and to validate novel therapies able to control the systemic disease. We report the development of a syngeneic (Balb/c) murine OSA model, using a cell line derived from a spontaneous murine tumor.. genes, already associated to the metastatic phenotype in human cancer.This OSA animal model faithfully recapitulates some of the most important features of the human malignancy, such as lung metastatization. Moreover, the non-invasive imaging allows monitoring the tumor progression in living mice. A great asset of this model is the metastatic phenotype, which is a stable property, not modif...
Osteosarcoma is the commonest primary tumour of bone and the second highest cause of cancer-related ...
BACKGROUND:Tumor cell lines that can be tracked in vivo during tumorigenesis and metastasis provide ...
Oncostatin M (OSM) is a multifunctional cytokine belonging to the interleukin (IL)-6 subfamily. OSM...
BACKGROUND: Osteosarcoma (OSA) is lethal when metastatic after chemotherapy and/or surgical treatmen...
Background: Osteosarcoma (OSA) is lethal when metastatic after chemotherapy and/or surgical treatmen...
Osteosarcoma (OS) is the most common non-hematologic primary tumor of bone in children and adults. H...
Osteosarcoma (OS) is a heterogeneous and rare disease with a disproportionate impact because it main...
As a reliable model for osteosarcoma is lacking, three human cell lines (SaOS-2, U2OS and 143B) were...
Osteosarcoma is rare and little improvement in survival rates has occurred in the last 25 years desp...
Osteosarcoma (OS) is the most common cancer of bone in children and young adults. Despite extensive ...
AbstractOsteosarcoma (OS) is a bone malignancy that affects children and adolescents. It is a highly...
Paediatric primary musculoskeletal (MS) cancers such as Ewing’s sarcoma and osteosarcoma account for...
Despite advances in the management of osteosarcoma (OSA) and other solid tumors, the development of ...
More effective treatment of patients with metastasizing osteosarcoma (OS) with a mean 5-year surviva...
Bone is the most prevalent metastatic site for breast cancer affecting ~70% of patients with late-st...
Osteosarcoma is the commonest primary tumour of bone and the second highest cause of cancer-related ...
BACKGROUND:Tumor cell lines that can be tracked in vivo during tumorigenesis and metastasis provide ...
Oncostatin M (OSM) is a multifunctional cytokine belonging to the interleukin (IL)-6 subfamily. OSM...
BACKGROUND: Osteosarcoma (OSA) is lethal when metastatic after chemotherapy and/or surgical treatmen...
Background: Osteosarcoma (OSA) is lethal when metastatic after chemotherapy and/or surgical treatmen...
Osteosarcoma (OS) is the most common non-hematologic primary tumor of bone in children and adults. H...
Osteosarcoma (OS) is a heterogeneous and rare disease with a disproportionate impact because it main...
As a reliable model for osteosarcoma is lacking, three human cell lines (SaOS-2, U2OS and 143B) were...
Osteosarcoma is rare and little improvement in survival rates has occurred in the last 25 years desp...
Osteosarcoma (OS) is the most common cancer of bone in children and young adults. Despite extensive ...
AbstractOsteosarcoma (OS) is a bone malignancy that affects children and adolescents. It is a highly...
Paediatric primary musculoskeletal (MS) cancers such as Ewing’s sarcoma and osteosarcoma account for...
Despite advances in the management of osteosarcoma (OSA) and other solid tumors, the development of ...
More effective treatment of patients with metastasizing osteosarcoma (OS) with a mean 5-year surviva...
Bone is the most prevalent metastatic site for breast cancer affecting ~70% of patients with late-st...
Osteosarcoma is the commonest primary tumour of bone and the second highest cause of cancer-related ...
BACKGROUND:Tumor cell lines that can be tracked in vivo during tumorigenesis and metastasis provide ...
Oncostatin M (OSM) is a multifunctional cytokine belonging to the interleukin (IL)-6 subfamily. OSM...